New website aims to ease tough fertility choices for women with cancer
NCT ID NCT03141437
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a decision aid website called Pathways to Fertility for women newly diagnosed with cancer who may face infertility from treatment. About 130 women will use the website or receive standard care to see if it helps them make more informed and less conflicted decisions about preserving their fertility. The goal is to improve decision quality, not to treat the cancer itself.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- decision aid website
- What this could lead to
- If successful, this could provide a proven tool to help women with cancer make clearer, more confident decisions about preserving their fertility before treatment.
- What could go wrong
- This is a behavioral study, not a treatment trial. It measures decision-making, not medical outcomes, so it won't directly improve survival or fertility rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 130 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2017
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newly diagnosed breast tumor, female genital system tumor, colorectal tumor, and/or lymphoma/myeloma * At risk for cancer-related infertility, as assessed by their clinician(s), including the oncofertility specialist * Must be able to speak, read, and write English * Must have internet access and a valid email address * Have not previously viewed the Pathways decision aid * For clinical provider participants: Clinical provider at a Houston Area Location of MD Anderson assigned to the intervention
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mitochondria-Targeting drug gamitrinib tested for first time in humans
- Reprogrammed immune cells target CD30-Positive lymphoma in early trial
- Can an experimental pill boost cancer immunotherapy? early trial puts HG146 to the test
- Can an oral drug replace injections for advanced breast cancer?
- Double-Drug attack on Hard-to-Treat lymphomas
- Chemotherapy plus immunotherapy tested against rare EBV-Driven immune storm